Search research articles
Contact Us
Filters
Showing results (111-120 of 135) with videos related to
Page
of 14
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 28, 2021
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
Cheng-Teng Ip, Sebastian Olbrich, Melanie Ganz, et al.
Journal of Psychiatric Research
|
June 27, 2021
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
Cheng-Teng Ip, Melanie Ganz, Vibeke H Dam, et al.
Inorganic Chemistry
|
February 28, 2006
A novel heteroditopic terpyridine-pincer ligand as building block for mono- and heterometallic Pd(II) and Ru(II) complexes
Marcella Gagliardo, Gema Rodríguez, Henk H Dam, et al.
Biochemistry
|
October 28, 1998
Dimerization of native myosin LC2(RLC)-free subfragment 1 from adult rabbit skeletal muscle
J E Morel, K Taouil, N D'hahan, et al.
Biological Psychiatry
|
August 24, 2024
Effect of Antidepressant Treatment on 5-HT<sub>4</sub> Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
Vibeke H Dam, Kristin Köhler-Forsberg, Brice Ozenne, et al.
Neuroscience Applied
|
July 14, 2025
The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsy
Maja R Marstrand-Joergensen, Vibeke H Dam, Kirsten Vinter, et al.
Translational Psychiatry
|
July 12, 2022
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
Kristin Köhler-Forsberg, Brice Ozenne, Søren V Larsen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 15, 2025
Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
Kamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 2, 2026
Correction: Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
Kamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Frontiers in Psychiatry
|
August 15, 2020
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
Kristin Köhler-Forsberg, Anders Jorgensen, Vibeke H Dam, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 135) with videos related to
Sort By:
Page
of 14
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 28, 2021
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
Cheng-Teng Ip, Sebastian Olbrich, Melanie Ganz, et al.
Journal of Psychiatric Research
|
June 27, 2021
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD
Cheng-Teng Ip, Melanie Ganz, Vibeke H Dam, et al.
Inorganic Chemistry
|
February 28, 2006
A novel heteroditopic terpyridine-pincer ligand as building block for mono- and heterometallic Pd(II) and Ru(II) complexes
Marcella Gagliardo, Gema Rodríguez, Henk H Dam, et al.
Biochemistry
|
October 28, 1998
Dimerization of native myosin LC2(RLC)-free subfragment 1 from adult rabbit skeletal muscle
J E Morel, K Taouil, N D'hahan, et al.
Biological Psychiatry
|
August 24, 2024
Effect of Antidepressant Treatment on 5-HT<sub>4</sub> Receptor Binding and Associations With Clinical Outcomes and Verbal Memory in Major Depressive Disorder
Vibeke H Dam, Kristin Köhler-Forsberg, Brice Ozenne, et al.
Neuroscience Applied
|
July 14, 2025
The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsy
Maja R Marstrand-Joergensen, Vibeke H Dam, Kirsten Vinter, et al.
Translational Psychiatry
|
July 12, 2022
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
Kristin Köhler-Forsberg, Brice Ozenne, Søren V Larsen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 15, 2025
Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
Kamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 2, 2026
Correction: Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
Kamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Frontiers in Psychiatry
|
August 15, 2020
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
Kristin Köhler-Forsberg, Anders Jorgensen, Vibeke H Dam, et al.
Page
of 14